Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antimicrobial Stewardship | 4 | 2023 | 97 | 1.800 |
Why?
|
| Iatrogenic Disease | 2 | 2021 | 197 | 1.280 |
Why?
|
| Bacteriuria | 2 | 2024 | 84 | 1.240 |
Why?
|
| Drug Utilization | 2 | 2020 | 190 | 1.140 |
Why?
|
| Anti-Bacterial Agents | 11 | 2024 | 3184 | 1.110 |
Why?
|
| Endocarditis, Bacterial | 2 | 2017 | 153 | 1.030 |
Why?
|
| Personal Protective Equipment | 2 | 2022 | 64 | 0.950 |
Why?
|
| Anti-Infective Agents | 3 | 2023 | 467 | 0.950 |
Why?
|
| Prosthesis-Related Infections | 2 | 2016 | 229 | 0.890 |
Why?
|
| Skin Diseases | 2 | 2017 | 366 | 0.870 |
Why?
|
| Eosinophilia | 2 | 2014 | 184 | 0.830 |
Why?
|
| Herpes Genitalis | 1 | 2021 | 16 | 0.790 |
Why?
|
| Communicable Diseases | 1 | 2023 | 210 | 0.740 |
Why?
|
| HIV Infections | 3 | 2021 | 2158 | 0.730 |
Why?
|
| Sexual and Gender Minorities | 1 | 2021 | 76 | 0.710 |
Why?
|
| Staphylococcal Infections | 3 | 2016 | 680 | 0.690 |
Why?
|
| Urine | 1 | 2020 | 139 | 0.680 |
Why?
|
| Staphylococcus aureus | 2 | 2014 | 561 | 0.680 |
Why?
|
| Sepsis | 2 | 2017 | 688 | 0.670 |
Why?
|
| Mandatory Programs | 1 | 2018 | 6 | 0.650 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 128 | 0.620 |
Why?
|
| Blood Culture | 2 | 2021 | 32 | 0.610 |
Why?
|
| Physicians | 3 | 2024 | 871 | 0.590 |
Why?
|
| Vibrio Infections | 1 | 2017 | 16 | 0.590 |
Why?
|
| Vibrio vulnificus | 1 | 2017 | 7 | 0.590 |
Why?
|
| Urinary Tract Infections | 2 | 2020 | 342 | 0.590 |
Why?
|
| Mycobacterium abscessus | 1 | 2017 | 11 | 0.580 |
Why?
|
| Candidiasis | 2 | 2016 | 280 | 0.580 |
Why?
|
| Blood Sedimentation | 1 | 2017 | 37 | 0.580 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2016 | 46 | 0.560 |
Why?
|
| Nocardia Infections | 1 | 2017 | 36 | 0.550 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2020 | 273 | 0.550 |
Why?
|
| Wound Infection | 1 | 2017 | 66 | 0.550 |
Why?
|
| Heart Valve Prosthesis | 2 | 2017 | 326 | 0.550 |
Why?
|
| Infection Control | 2 | 2016 | 276 | 0.550 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2017 | 88 | 0.550 |
Why?
|
| Peritonitis | 1 | 2016 | 98 | 0.540 |
Why?
|
| Brain Abscess | 1 | 2017 | 69 | 0.540 |
Why?
|
| Case Management | 1 | 2016 | 37 | 0.540 |
Why?
|
| Methyltransferases | 1 | 2017 | 153 | 0.520 |
Why?
|
| Professional Competence | 1 | 2017 | 134 | 0.520 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2016 | 89 | 0.510 |
Why?
|
| Leukocyte Count | 1 | 2017 | 737 | 0.510 |
Why?
|
| Inpatients | 1 | 2021 | 697 | 0.510 |
Why?
|
| Quality Improvement | 2 | 2022 | 919 | 0.510 |
Why?
|
| Health Personnel | 1 | 2021 | 657 | 0.500 |
Why?
|
| Opportunistic Infections | 1 | 2017 | 237 | 0.500 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 361 | 0.490 |
Why?
|
| Specimen Handling | 1 | 2017 | 314 | 0.490 |
Why?
|
| Endocarditis | 1 | 2016 | 127 | 0.480 |
Why?
|
| Diabetic Foot | 1 | 2017 | 158 | 0.480 |
Why?
|
| Joint Prosthesis | 1 | 2014 | 15 | 0.480 |
Why?
|
| Arthroplasty | 1 | 2014 | 22 | 0.470 |
Why?
|
| Mucormycosis | 1 | 2016 | 118 | 0.470 |
Why?
|
| Abscess | 1 | 2016 | 192 | 0.470 |
Why?
|
| Osteomyelitis | 1 | 2017 | 260 | 0.460 |
Why?
|
| Drainage | 1 | 2016 | 451 | 0.430 |
Why?
|
| Mycoses | 1 | 2016 | 396 | 0.410 |
Why?
|
| Immunocompromised Host | 4 | 2019 | 720 | 0.410 |
Why?
|
| Neutrophils | 1 | 2017 | 875 | 0.410 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 408 | 0.410 |
Why?
|
| Education, Medical | 1 | 2016 | 344 | 0.410 |
Why?
|
| Bacteremia | 2 | 2021 | 721 | 0.400 |
Why?
|
| Lymphocytes | 1 | 2017 | 1279 | 0.400 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2017 | 749 | 0.370 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 920 | 0.360 |
Why?
|
| Texas | 5 | 2024 | 6444 | 0.340 |
Why?
|
| Catheter-Related Infections | 1 | 2012 | 276 | 0.330 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 1233 | 0.320 |
Why?
|
| Humans | 33 | 2024 | 271550 | 0.300 |
Why?
|
| Substance Abuse, Intravenous | 2 | 2017 | 47 | 0.280 |
Why?
|
| Fatal Outcome | 2 | 2017 | 832 | 0.240 |
Why?
|
| Tertiary Care Centers | 2 | 2017 | 420 | 0.210 |
Why?
|
| Urinary Catheterization | 2 | 2013 | 135 | 0.210 |
Why?
|
| Interdisciplinary Studies | 1 | 2022 | 6 | 0.210 |
Why?
|
| Postoperative Complications | 2 | 2016 | 5697 | 0.200 |
Why?
|
| Male | 14 | 2021 | 128724 | 0.200 |
Why?
|
| Hospitals | 2 | 2022 | 492 | 0.200 |
Why?
|
| Benchmarking | 1 | 2023 | 282 | 0.190 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2016 | 290 | 0.190 |
Why?
|
| Homosexuality, Male | 1 | 2021 | 75 | 0.190 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2021 | 33 | 0.190 |
Why?
|
| Sexual Partners | 1 | 2021 | 103 | 0.190 |
Why?
|
| Attitude | 1 | 2021 | 163 | 0.180 |
Why?
|
| Masks | 1 | 2021 | 56 | 0.180 |
Why?
|
| Echocardiography | 2 | 2017 | 1230 | 0.180 |
Why?
|
| Catholicism | 1 | 2020 | 7 | 0.180 |
Why?
|
| Hospitals, Religious | 1 | 2020 | 8 | 0.180 |
Why?
|
| Disclosure | 1 | 2021 | 182 | 0.180 |
Why?
|
| Documentation | 1 | 2022 | 216 | 0.180 |
Why?
|
| Antifungal Agents | 2 | 2016 | 876 | 0.170 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 4505 | 0.170 |
Why?
|
| Sexual Behavior | 1 | 2021 | 313 | 0.160 |
Why?
|
| Logistic Models | 2 | 2018 | 3455 | 0.160 |
Why?
|
| Intensive Care Units | 1 | 2023 | 738 | 0.160 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 560 | 0.150 |
Why?
|
| Cyclonic Storms | 1 | 2019 | 84 | 0.150 |
Why?
|
| Disasters | 1 | 2019 | 107 | 0.150 |
Why?
|
| Fungi | 1 | 2019 | 148 | 0.150 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2017 | 214 | 0.150 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 4895 | 0.150 |
Why?
|
| Sulfadoxine | 1 | 2017 | 2 | 0.140 |
Why?
|
| Trimethoprim | 1 | 2017 | 7 | 0.140 |
Why?
|
| Environmental Exposure | 1 | 2019 | 288 | 0.140 |
Why?
|
| beta-Glucans | 1 | 2016 | 35 | 0.140 |
Why?
|
| Device Removal | 2 | 2016 | 338 | 0.140 |
Why?
|
| Skin Diseases, Infectious | 1 | 2016 | 26 | 0.140 |
Why?
|
| Microbiological Techniques | 1 | 2016 | 41 | 0.130 |
Why?
|
| Histoplasmosis | 1 | 2016 | 80 | 0.130 |
Why?
|
| Program Evaluation | 1 | 2018 | 611 | 0.130 |
Why?
|
| Proteoglycans | 1 | 2016 | 279 | 0.130 |
Why?
|
| Immunocompetence | 1 | 2016 | 73 | 0.130 |
Why?
|
| Pneumonia, Bacterial | 1 | 2017 | 135 | 0.130 |
Why?
|
| Fungemia | 1 | 2016 | 119 | 0.130 |
Why?
|
| Students, Pharmacy | 1 | 2016 | 62 | 0.130 |
Why?
|
| Multiple Organ Failure | 1 | 2017 | 177 | 0.130 |
Why?
|
| Candida albicans | 1 | 2016 | 187 | 0.130 |
Why?
|
| Soft Tissue Infections | 1 | 2016 | 94 | 0.130 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2016 | 173 | 0.120 |
Why?
|
| Drug Combinations | 1 | 2017 | 635 | 0.120 |
Why?
|
| Community-Acquired Infections | 1 | 2017 | 286 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 876 | 0.120 |
Why?
|
| Leg | 1 | 2016 | 216 | 0.120 |
Why?
|
| Amphotericin B | 1 | 2016 | 304 | 0.120 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2017 | 189 | 0.120 |
Why?
|
| Aspergillosis | 1 | 2016 | 248 | 0.120 |
Why?
|
| Dyspnea | 1 | 2017 | 420 | 0.110 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 296 | 0.110 |
Why?
|
| Disease Susceptibility | 1 | 2016 | 543 | 0.110 |
Why?
|
| Asymptomatic Infections | 1 | 2013 | 35 | 0.110 |
Why?
|
| Defibrillators, Implantable | 1 | 2016 | 224 | 0.110 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 689 | 0.110 |
Why?
|
| Aged | 5 | 2024 | 73451 | 0.110 |
Why?
|
| Middle Aged | 6 | 2017 | 90422 | 0.110 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 552 | 0.110 |
Why?
|
| Viral Load | 1 | 2014 | 482 | 0.100 |
Why?
|
| Exanthema | 1 | 2014 | 211 | 0.100 |
Why?
|
| Skin | 1 | 2017 | 1281 | 0.100 |
Why?
|
| Length of Stay | 1 | 2018 | 2010 | 0.100 |
Why?
|
| Triazoles | 1 | 2016 | 629 | 0.100 |
Why?
|
| Biliary Tract Diseases | 1 | 2011 | 65 | 0.100 |
Why?
|
| Students, Medical | 1 | 2016 | 421 | 0.090 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2011 | 44 | 0.090 |
Why?
|
| Heroin Dependence | 1 | 2011 | 60 | 0.090 |
Why?
|
| Zygomycosis | 1 | 2011 | 30 | 0.090 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2012 | 213 | 0.090 |
Why?
|
| Spinal Cord Injuries | 1 | 2013 | 349 | 0.090 |
Why?
|
| Adult | 4 | 2023 | 82003 | 0.080 |
Why?
|
| Hepatitis E | 1 | 2008 | 13 | 0.080 |
Why?
|
| Female | 7 | 2018 | 149106 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 1167 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 635 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 6205 | 0.070 |
Why?
|
| Prevalence | 1 | 2014 | 3413 | 0.070 |
Why?
|
| Risk Factors | 2 | 2013 | 17982 | 0.060 |
Why?
|
| Biomarkers | 1 | 2017 | 5086 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2021 | 39818 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2014 | 6234 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 5936 | 0.060 |
Why?
|
| Inflammation | 1 | 2014 | 2531 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2016 | 13385 | 0.060 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2008 | 432 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2011 | 1192 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2014 | 9477 | 0.050 |
Why?
|
| United States | 1 | 2018 | 16006 | 0.050 |
Why?
|
| Emergencies | 1 | 2022 | 226 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 7792 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 7916 | 0.040 |
Why?
|
| Public Health | 1 | 2022 | 296 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 192 | 0.040 |
Why?
|
| Prognosis | 1 | 2017 | 22524 | 0.040 |
Why?
|
| Invasive Fungal Infections | 1 | 2019 | 54 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2022 | 410 | 0.040 |
Why?
|
| beta-Lactams | 1 | 2017 | 63 | 0.040 |
Why?
|
| Macrolides | 1 | 2017 | 65 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 1115 | 0.040 |
Why?
|
| Fluoroquinolones | 1 | 2017 | 132 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2023 | 973 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 15903 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2016 | 207 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2017 | 1430 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 31066 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 2357 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 2659 | 0.020 |
Why?
|
| Hepatitis E virus | 1 | 2008 | 11 | 0.020 |
Why?
|
| Syndrome | 1 | 2011 | 1401 | 0.020 |
Why?
|
| Calcinosis | 1 | 2011 | 431 | 0.020 |
Why?
|
| Hormones | 1 | 2008 | 292 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 6845 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2011 | 1935 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2013 | 33870 | 0.010 |
Why?
|
| Pregnancy | 1 | 2008 | 8110 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 22190 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 62359 | 0.000 |
Why?
|